Did NHRC Initiate Investigation into Spurious Cough Syrup After 12 Child Fatalities in MP and Rajasthan?

Synopsis
Key Takeaways
- NHRC takes serious action on child safety.
- Investigation into spurious cough syrup launched.
- Health departments to conduct immediate inquiries.
- Possible violations of children's fundamental rights.
- Urgent need for stringent drug regulations.
New Delhi, Oct 6 (NationPress) The National Human Rights Commission (NHRC) has issued official notices to the Principal Secretaries of the Health Departments in Madhya Pradesh and Rajasthan regarding the tragic deaths of twelve children who reportedly consumed what is suspected to be spurious cough syrup in various regions of both states.
A bench led by NHRC Member Priyank Kanoongo took note of a complaint highlighting significant failures in drug safety and regulatory practices that contributed to this unfortunate incident.
The complaint called for immediate action from the apex human rights organization concerning the reported incidents in Chhindwara and Vidisha districts of Madhya Pradesh, as well as specific areas in Rajasthan, where it is alleged that children died after consuming the cough syrup.
While preliminary tests conducted by the Union Health Ministry did not find traces of diethylene glycol or ethylene glycol—known toxins for kidney damage—the precise cause of these fatalities remains undetermined.
Numerous cases have been linked to kidney failure and related health issues. The complainant has described this situation as a breach of children's fundamental rights, including the right to life, health, and access to safe medications.
The complaint demands a thorough investigation into the manufacturing, distribution, regulatory failures, and possible contamination connected to the cough syrup's sale.
In accordance with Section 12 of the Protection of Human Rights Act, 1993, the NHRC has formally issued notices to the Principal Secretaries of the Health and Family Welfare Departments of the governments of MP, Rajasthan, and Uttar Pradesh, urging them to promptly investigate the allegations.
They have been instructed to collect samples of the cough syrup, test them in their respective laboratories, and immediately prohibit the sale of any counterfeit medications.
At the same time, the NHRC has instructed the Drugs Controller General of India (DCGI), along with the Central Drugs Standard Control Organisation and the Union Ministry of Health and Family Welfare, to launch a detailed investigation into the supply chain of the suspected counterfeit drugs. Additionally, all regional laboratories in the affected states are to gather and test samples.
“Moreover, all Chief Drugs Controllers in the relevant states are directed to expedite the process of banning the counterfeit medications and submit reports,” stated the apex human rights entity.
All relevant authorities have been mandated to provide an Action Taken Report (ATR) to the NHRC within a fortnight for further review.